Apogee Therapeutics (APGE) Treasury Shares (2022 - 2026)
Apogee Therapeutics (APGE) reported Treasury Shares of $441330.0 for Q1 2026, up 79.96% year-over-year from $245244.0 in Q1 2025, and down 30.78% quarter-over-quarter from $637594.0 in Q4 2025.
Apogee Therapeutics (APGE) Treasury Shares (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of Treasury Shares data on file, last reported at $441330.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $441330.0, up 79.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $441330.0 (up 79.96% YoY), and the FY2025 annual result was $637594.0, down 54.97% from the prior year.
- Treasury Shares slipped to $441330.0 in Q1 2026 per APGE's latest filing, from $637594.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $8.0 million in Q4 2022 and troughed at $126101.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $832249.5 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares tumbled 98.2% in 2023, then jumped 882.6% in 2024.
- A 5-year view of Treasury Shares shows it stood at $8.0 million in 2022, then plunged by 98.2% to $144090.0 in 2023, then jumped by 882.6% to $1.4 million in 2024, then plunged by 54.97% to $637594.0 in 2025, then slumped by 30.78% to $441330.0 in 2026.
- Business Quant data shows APGE's Treasury Shares at $441330.0 in Q1 2026, $637594.0 in Q4 2025, and $196132.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - | 441,330.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441,330.00 |
| Mar 31, 2026 | 441,330.00 |
| Dec 31, 2025 | 637,594.00 |
| Dec 31, 2025 | 637,594.00 |
| Sep 30, 2025 | 196,132.00 |
| Sep 30, 2025 | 196,132.00 |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 245,244.00 |
| Mar 31, 2025 | 245,244.00 |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 126,101.00 |
| Jun 30, 2024 | 126,101.00 |
| Mar 31, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 144,090.00 |
| Dec 31, 2023 | 144,090.00 |